Clinical Trial Update: Randomized Comparative Efficacy and Safety Study of Intermittent Simvastatin and Fenofibrate in Hemodialysis [Phase 4]

View source ↗

Summary

A Phase 4 randomized study compares intermittent simvastatin and fenofibrate for efficacy and safety in patients undergoing hemodialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Hyperlipidemia

Drugs mentioned

• FENOFIBRATE (Fenofibrate)
• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Cairo University | Conditions: Fenofibrate/Simvastatin Comparison | Phase 4 | Status: COMPLETED